BREAKING NEWS
This content is not available in your region

AstraZeneca gets FDA breakthrough therapy label for asthma treatment

Access to the comments Comments
AstraZeneca gets FDA breakthrough therapy label for asthma treatment
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London April 28, 2014. REUTERS/Stefan Wermuth/File Photo   -   Copyright  Stefan Wermuth(Reuters)
Text size Aa Aa

(Reuters) – AstraZeneca Plc <AZN.L> said on Friday the U.S. Food and Drug Administration had granted a breakthrough therapy label for its drug to treat a type of severe asthma, potentially speeding up its development and review.

The drug, Tezepelumab, is developed by British-listed AstraZeneca and its U.S. partner Amgen Inc <AMGN.O>.

(Reporting by Nivedita Balu in Bengaluru; Editing by Sai Sachin Ravikumar)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.